Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients (FLOXTOX2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01641458
Recruitment Status : Completed
First Posted : July 16, 2012
Last Update Posted : February 2, 2016
Sponsor:
Collaborator:
University of Bern
Information provided by (Responsible Party):
Markus Joerger, Cantonal Hospital of St. Gallen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2015
Actual Study Completion Date : November 2015